Related Experiment Video
Updated: Aug 12, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Polyarteritis nodosa and the antiphospholipid syndrome
R Schoonjans1, B Van Vlem, S Weyers
1Department of Gastroenterology, University Hospital, Ghent, Belgium.
This case study details polyarteritis nodosa (classic type) linked with antiphospholipid syndrome. Treatment with methylprednisolone and cyclophosphamide led to symptom improvement and normalized antibody levels.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Polyarteritis nodosa (PAN) is a systemic vasculitis affecting medium-sized arteries.
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombotic events.
- The co-occurrence of classic PAN and APS is rare, with limited reported cases.
Observation:
- A patient presented with biopsy-proven classic polyarteritis nodosa.
- Visceral angiography confirmed medium-sized arteriopathy.
- Elevated anticardiolipin antibodies, a marker for APS, were detected prior to treatment.
Findings:
- Treatment involved methylprednisolone and intravenous pulse cyclophosphamide.
- Patients experienced rapid symptom subsidence.
- Erythrocyte sedimentation rate normalized gradually, and anticardiolipin antibodies returned to normal limits within six months.
Implications:
- This case highlights the potential association between classic PAN and APS.
- Effective treatment strategies may involve immunosuppression and cyclophosphamide.
- Further research is warranted to understand the pathophysiology and optimal management of this rare condition.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nephrotic Syndrome I : Introduction

